Olivia Council
Clinical Research Coordinator
Medicine
School of Medicine

Publications (18)

Top publication keywords:
SemenHIV InfectionsProvirusesMedication AdherenceTriazolesSexually Transmitted DiseasesAnti-HIV AgentsPre-Exposure Prophylaxisenv Gene Products, Human Immunodeficiency VirusViral TropismCyclohexanesUrethritisVaginaCD4-Positive T-LymphocytesHIV-1

• A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage.
  The Journal of infectious diseases 2026 Moeser MJ, Council OD, Long N, Kincer L, Dennis AM, Eron J, Wohl D, Farel CE, Dittmer DP, Pluta L, Nelson J, Mohammadi A, Etemad B, Li JZ, McGann H, Smit E, Clement M, Yau T, Menezes P, Bowman NM, …
• A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage.
  bioRxiv : the preprint server for biology 2025 Moeser MJ, Council OD, Long N, Kincer L, Dennis AM, Eron J, Wohl D, Farel CE, Nelson J, Mohammadi A, Etemad B, Li JZ, McGann H, Smit E, Clement M, Yau T, Menezes P, Bowman NM, Zhou S, Joseph SB
• HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation.
  bioRxiv : the preprint server for biology 2025 Tyers L, Moeser M, Ntuli J, Council O, Zhou S, Spielvogel E, Sondgeroth A, Adams C, Thebus R, Yssel A, Karim SA, Garrett N, Pond SK, Williamson C, Swanstrom R, Abrahams MR, Joseph SB
• The persistent pool of HIV-1-infected cells is formed episodically during untreated infection.
  Journal of virology 2024 Council OD, Tyers L, Moeser M, Sondgeroth A, Spielvogel E, Richardson BD, Doolabh D, Zhou S, Emery A, Archin NM, Shook-Sa B, Margolis DM, Abdool Karim SS, Kosakovsky Pond S, Garrett N, Abrahams M-R, …
• The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
  PLoS pathogens 2024 Joseph SB, Abrahams MR, Moeser M, Tyers L, Archin NM, Council OD, Sondgeroth A, Spielvogel E, Emery A, Zhou S, Doolabh D, Ismail SD, Karim SA, Margolis DM, Pond SK, Garrett N, Swanstrom R, Williamson …

Show all (13 more) Hide

• Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Ismail SD, Riou C, Joseph SB, Archin NM, Margolis DM, Perelson AS, Cassidy T, Abrahams MR, Moeser M, Council OD, McKinnon LR, Osman F, Karim QA, Abdool Karim SS, Swanstrom R, Williamson C, Garrett NJ,…
• The HIV-1 latent reservoir is largely sensitive to circulating T cells.
  eLife 2020 Warren JA, Zhou S, Xu Y, Moeser MJ, MacMillan DR, Council O, Kirchherr J, Sung JM, Roan NR, Adimora AA, Joseph S, Kuruc JD, Gay CL, Margolis DM, Archin N, Brumme ZL, Swanstrom R, Goonetilleke N
• Deep Sequencing Reveals Compartmentalized HIV-1 in the Semen of Men with and without Sexually Transmitted Infection-Associated Urethritis.
  Journal of virology 2020 Council OD, Zhou S, McCann CD, Hoffman I, Tegha G, Kamwendo D, Matoga M, Kosakovsky Pond SL, Cohen MS, Swanstrom R
• HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
  AIDS research and human retroviruses 2020 Adewumi OM, Dukhovlinova E, Shehu NY, Zhou S, Council OD, Akanbi MO, Taiwo B, Ogunniyi A, Robertson K, Kanyama C, Hosseinipour MC, Swanstrom R
• HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.
  AIDS (London, England) 2019 Council OD, Ruone S, Mock PA, Khalil G, Martin A, Curlin ME, McNicholl JM, Heneine W, Leelawiwat W, Choopanya K, Vanichseni S, Cherdtrakulkiat T, Anekvorapong R, Martin M, García-Lerma JG
• The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.
  Science translational medicine 2019 Abrahams MR, Joseph SB, Garrett N, Tyers L, Moeser M, Archin N, Council OD, Matten D, Zhou S, Doolabh D, Anthony C, Goonetilleke N, Karim SA, Margolis DM, Pond SK, Williamson C, Swanstrom R
• Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy.
  Journal of the International AIDS Society 2019 Cohen MS, Council OD, Chen JS
• Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection.
  Nature communications 2019 Radzio-Basu J, Council O, Cong ME, Ruone S, Newton A, Wei X, Mitchell J, Ellis S, Petropoulos CJ, Huang W, Spreen W, Heneine W, García-Lerma JG
• Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies.
  Nature communications 2019 Zhu C, Dukhovlinova E, Council O, Ping L, Faison EM, Prabhu SS, Potter EL, Upton SL, Yin G, Fay JM, Kincer LP, Spielvogel E, Campbell SL, Benhabbour SR, Ke H, Swanstrom R, Dokholyan NV
• Evolution of Host Target Cell Specificity During HIV-1 Infection.
  Current HIV research 2018 Council OD, Joseph SB
• Correction: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.
  PLoS pathogens 2015 Kovarova M, Council OD, Date AA, Long JM, Nochi T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV
• Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection.
  Antimicrobial agents and chemotherapy 2015 Council OD, Swanson MD, Spagnuolo RA, Wahl A, Garcia JV
• Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.
  PLoS pathogens 2015 Kovarova M, Council OD, Date AA, Long JM, Nochi T, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV